ir.prothena.comInvestor Relations | Prothena Corporation plc
ir.prothena.com Profile
Ir.prothena.com is a subdomain of prothena.com, which was created on 2012-10-18,making it 12 years ago.
Discover ir.prothena.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.prothena.com Information
| HomePage size: 76.241 KB |
| Page Load Time: 0.276443 Seconds |
| Website IP Address: 162.159.129.11 |
ir.prothena.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.prothena.com PopUrls
| Investor Relations | Prothena Corporation plc https://ir.prothena.com/overview/default.aspx |
| Financials & Filings - Overview | Prothena Corporation plc https://ir.prothena.com/investors/financials-filings/overview/default.aspx |
| Press Releases - Investor Relations | Prothena Corporation plc https://ir.prothena.com/investors/press-releases/ |
| Stock Information - Investor Relations | Prothena Corporation plc https://ir.prothena.com/investors/stock-information/default.aspx |
| Investors - Events & Presentations | Prothena Corporation plc https://ir.prothena.com/investors/events-and-presentations/default.aspx |
| Stock Information - Investor Relations | Prothena Corporation plc https://ir.prothena.com/investors/stock-information/ |
| Investors - Corporate Governance https://ir.prothena.com/investors/corporate-governance/corporate-governance/ |
| Press Releases Details | Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2023/ |
| Prothena Announces Appointment of Chief Regulatory Officer https://ir.prothena.com/investors/press-releases/news-details/2016/Prothena-Announces-Appointment-of-Chief-Regulatory-Officer/default.aspx |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-F |
| Prothena Presents New Research in the Treatment of Alzheimer’s Disease ... https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-Presents-New-Research-in-the-Treatment-of-Alzheimers-Disease-at-Alzheimers |
| Prothena Reports Fourth Quarter and Full Year 2023 Financial Results ... https://ir.prothena.com/investors/press-releases/news-details/2024/Prothena-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-F |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-Reports-First-Quarter-2023-Financial-Results-and-Business-Highlights/defau |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2021/Prothena-and-Novo-Nordisk-Announce-Acquisition-Agreement-for-Prothenas-ATTR-Amyloid |
| Press Releases Details - Prothena Corporation plc https://ir.prothena.com/investors/press-releases/news-details/2023/Prothena-to-Highlight-Next-Generation-Treatments-for-Alzheimers-and-Parkinsons-Dise |
ir.prothena.com Httpheader
| Date: Tue, 14 May 2024 03:56:35 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 8837f58ec869174a-SJC |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
ir.prothena.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="1111111111 Replace Me" name="google-site-verification"/ |
ir.prothena.com Html To Plain Text
OverviewOur Science Pipeline Clinical Trials News Center Investors Overview Press Releases Events & Presentations Stock Information Stock Information Analyst Coverage Financials & Filings Overview Quarterly Results SEC Filings Irish Statutory Financial Statements Proxy Statements Corporate Governance Corporate Governance Committee Composition Executive Management Board of Directors Investor Resources Investor Email Alerts Careers Overview Press Releases Events & Presentations Stock Information Financials & Filings Corporate GovernanceCorporate Governance Investor Resources Investor Relations Corporate Overview Prothena Corporation plc (Nasdaq: PRTA) is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Prothena leverages insights into the biology of misfolded proteins to develop novel therapeutic solutions that directly target pathogenic proteins in order to change the course of devastating diseases. Learn More Latest Press Releases View all press releases Upcoming Events Oppenheimer 33rd Annual Healthcare Conference - Fireside Chat Oppenheimer 33rd Annual Healthcare Conference - Fireside Chat (opens in new window) WebcastView all events 1800 Sierra Point Parkway Brisbane, CA 94005 U.S.A.News Center Careers Contact UsFollow us follow us on twitter follow us on linked in © Prothena - All rights reserved Powered By Q4 Inc. 5.80.0.1 (opens in new window) Terms of Use Privacy...
ir.prothena.com Whois
Domain Name: PROTHENA.COM Registry Domain ID: 1753140545_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2022-08-02T02:31:25Z Creation Date: 2012-10-18T21:37:11Z Registry Expiry Date: 2027-10-18T21:37:11Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.IDP365.NET Name Server: DNS2.IDP365.NET Name Server: DNS3.IDP365.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:05:52Z <<<